Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boston Pharmaceuticals Widens Opportunities With New GSK Assets

Company In-Licenses Oncology, Neurology Drugs

Mar 18 2021

• By Alaric DeArment

Business Growth Concept_1089895325_1200.jpg — Boston Pharmaceuticals has taken on two new assets under its 2018 deal with GlaxoSmithKline. • Source: Shutterstock

Related Content

Back In Fashion? Boston’s CBO Talks Turkey On Reinvigorating Pharma’s Unwanted Assets

Nov 12 2018

Boston Pharmaceuticals: A New Model To De-Risk Drugs

Dec 30 2015

Boston Bags Assets From GSK and Novartis

Oct 03 2018

Related Companies

Boston Pharmaceuticals Inc.

GSK plc

Novartis AG

Daiichi Sankyo Co., Ltd.

AstraZeneca PLC

Eli Lilly and Company

Roche Holding AG

Additional Topics

Research & Development Business Strategies Deals Cancer Neurology

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window